142 related articles for article (PubMed ID: 36790831)
21. Rationale and design of a multicenter prospective cohort study for the eVALuation and monitoring of HPV infections and relATEd cervical diseases in high-risk women (VALHIDATE study).
Orlando G; Tanzi E; Chatenoud L; Gramegna M; Rizzardini G;
BMC Cancer; 2012 May; 12():204. PubMed ID: 22646512
[TBL] [Abstract][Full Text] [Related]
22. Association of Chlamydia trachomatis infection with redetection of human papillomavirus after apparent clearance.
Shew ML; Ermel AC; Weaver BA; Tong Y; Tu W; Kester LM; Denski C; Fortenberry JD; Brown DR
J Infect Dis; 2013 Nov; 208(9):1416-21. PubMed ID: 23911713
[TBL] [Abstract][Full Text] [Related]
23. Comparison of human papillomavirus genotyping and cytology triage, COMPACT Study: Design, methods and baseline results in 14 642 women.
Aoyama-Kikawa S; Fujita H; Hanley SJB; Kasamo M; Kikuchi K; Torigoe T; Matsuno Y; Tamakoshi A; Sasaki T; Matsuura M; Kato Y; Dong P; Watari H; Saito T; Sengoku K; Sakuragi N
Cancer Sci; 2018 Jun; 109(6):2003-2012. PubMed ID: 29660849
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease.
Kreimer AR; Guido RS; Solomon D; Schiffman M; Wacholder S; Jeronimo J; Wheeler CM; Castle PE
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):908-14. PubMed ID: 16702369
[TBL] [Abstract][Full Text] [Related]
25. [Genotype distribution of human papillomavirus in women from the state of Bahia, Brazil].
Bruno A; Serravalle K; Travassos AG; Lima BG
Rev Bras Ginecol Obstet; 2014 Sep; 36(9):416-22. PubMed ID: 25272363
[TBL] [Abstract][Full Text] [Related]
26. Human Papillomavirus (HPV) seroprevalence, cervical HPV prevalence, genotype distribution and cytological lesions in solid organ transplant recipients and immunocompetent women in Sao Paulo, Brazil.
Miyaji KT; Infante V; Picone CM; Levi JE; Oliveira ACS; Lara AN; Tacla M; Dillner J; Kann H; Eklund C; Castanheira CP; Mayaud P; Sartori AMC;
PLoS One; 2022; 17(1):e0262724. PubMed ID: 35051227
[TBL] [Abstract][Full Text] [Related]
27. Enhanced disease progression due to persistent HPV-16/58 infections in Korean women: a systematic review and the Korea HPV cohort study.
Seong J; Ryou S; Lee J; Yoo M; Hur S; Choi BS;
Virol J; 2021 Sep; 18(1):188. PubMed ID: 34535177
[TBL] [Abstract][Full Text] [Related]
28. High-Risk HPV Testing in Primary Screening for Cervical Cancer in the Public Health System, São Paulo, Brazil.
Levi JE; Martins TR; Longatto-Filho A; Cohen DD; Cury L; Fuza LM; Villa LL; Eluf-Neto J
Cancer Prev Res (Phila); 2019 Aug; 12(8):539-546. PubMed ID: 31189569
[TBL] [Abstract][Full Text] [Related]
29. Risk stratification for cervical precancer and cancer by DH3-HPV partial genotyping and cytology in women attending cervical screening: A retrospective cohort study.
Fu Y; Li Y; Li X; Wang X; Lü W
J Med Virol; 2023 Feb; 95(2):e28482. PubMed ID: 36609841
[TBL] [Abstract][Full Text] [Related]
30. Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study.
Castle PE; Rodríguez AC; Burk RD; Herrero R; Wacholder S; Alfaro M; Morales J; Guillen D; Sherman ME; Solomon D; Schiffman M;
BMJ; 2009 Jul; 339():b2569. PubMed ID: 19638649
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of human papillomavirus infection among women from quilombo communities in northeastern Brazil.
Nascimento MDDSB; Vidal FCB; Silva MACND; Batista JE; Lacerda Barbosa MDC; Muniz Filho WE; Bezerra GFB; Castro Viana GM; Branco RCC; Brito LMO
BMC Womens Health; 2018 Jan; 18(1):1. PubMed ID: 29291721
[TBL] [Abstract][Full Text] [Related]
32. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females.
Moscicki AB; Hills N; Shiboski S; Powell K; Jay N; Hanson E; Miller S; Clayton L; Farhat S; Broering J; Darragh T; Palefsky J
JAMA; 2001 Jun; 285(23):2995-3002. PubMed ID: 11410098
[TBL] [Abstract][Full Text] [Related]
33. Contributions of recent and past sexual partnerships on incident human papillomavirus detection: acquisition and reactivation in older women.
Rositch AF; Burke AE; Viscidi RP; Silver MI; Chang K; Gravitt PE
Cancer Res; 2012 Dec; 72(23):6183-90. PubMed ID: 23019223
[TBL] [Abstract][Full Text] [Related]
34. Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland.
Leinonen MK; Nieminen P; Lönnberg S; Malila N; Hakama M; Pokhrel A; Laurila P; Tarkkanen J; Anttila A
BMJ; 2012 Nov; 345():e7789. PubMed ID: 23197596
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia.
Schlecht NF; Platt RW; Duarte-Franco E; Costa MC; Sobrinho JP; Prado JC; Ferenczy A; Rohan TE; Villa LL; Franco EL
J Natl Cancer Inst; 2003 Sep; 95(17):1336-43. PubMed ID: 12953088
[TBL] [Abstract][Full Text] [Related]
36. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
37. Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.
Učakar V; Poljak M; Oštrbenk A; Klavs I
J Med Virol; 2014 Oct; 86(10):1772-9. PubMed ID: 24978445
[TBL] [Abstract][Full Text] [Related]
38. Is human papillomavirus genotype important in predicting disease progression in women with biopsy-proven negative or CIN1 of atypical squamous cell of undetermined significance (ASC-US) cytology?
Kang WD; Ju UC; Kim SM
Gynecol Oncol; 2018 Feb; 148(2):305-310. PubMed ID: 29183629
[TBL] [Abstract][Full Text] [Related]
39. Risk of precancer determined by HPV genotype combinations in women with minor cytologic abnormalities.
Gage JC; Schiffman M; Solomon D; Wheeler CM; Gravitt PE; Castle PE; Wentzensen N
Cancer Epidemiol Biomarkers Prev; 2013 Jun; 22(6):1095-101. PubMed ID: 23603204
[TBL] [Abstract][Full Text] [Related]
40. Human papillomavirus prevalence and genotype distribution among Turkish women with or without cervical lesion.
Demirci M; Guzel AD; Ersahin AA; Yorulmaz E; Ersahin SS; Borsa BA
Indian J Med Microbiol; 2018; 36(4):517-521. PubMed ID: 30880699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
